Bitter melon: antagonist to cancer.

Area of Science:

• Oncology
• Nutritional Science
• Traditional Medicine

Background:

• Global cancer incidence is rising despite advances in therapies.
• Dietary interventions are explored for cancer prevention by inhibiting neoplastic events.
• Bitter melon (Momordica charantia) is an Ayurvedic remedy with a history of use for diabetes and potential anti-cancer properties.

Purpose of the Study:

• To review recent advancements in the chemopreventive and anti-cancer efficacy of bitter melon and its constituents.
• To highlight bitter melon's potential role in cancer control through dietary intervention.

Main Methods:

• Review of scientific literature on bitter melon's anti-cancer effects.
• Analysis of studies investigating bitter melon's impact on cancer cell lines.
• Examination of bitter melon's mechanism of action, including cell cycle regulation and apoptosis induction.

Main Results:

• Bitter melon extracts demonstrate anti-tumor activity in various cancer cell lines.
• Treatment with bitter melon products induces cell cycle arrest and apoptosis.
• These effects occur without adversely impacting normal cell growth, indicating selectivity.
• Bitter melon exhibits a low side-effect profile in animal and human studies.

Conclusions:

• Bitter melon possesses significant cancer chemopreventive and anti-cancer potential.
• Its active constituents can inhibit carcinogenesis by regulating cell homeostasis and apoptosis.
• Bitter melon represents a safe, cost-effective, and beneficial dietary approach for cancer health.